Literature DB >> 17103483

Gallbladder disease in the general population: association with cardiovascular morbidity and therapy.

Antonio González-Pérez1, Luis A García Rodríguez.   

Abstract

PURPOSE: Both gallbladder (GB) and cardiovascular disease are very common diagnoses that carry substantial economic costs. Prior studies suggest that personal history of ischaemic heart disease (IHD) could determine the occurrence of GB disease. Additionally the use of thiazide diuretics may also be a risk factor for this condition. We aimed to evaluate different cardiovascular conditions and related drugs that could be associated with GB disease.
METHODS: We identified all incident cases of gallbladder disease occurring during 1996 among patients aged 20-79 years old registered in the General Practitioner Research Database. We performed a nested case control analysis using 2353 cases and 10,000 controls frequency matched to the cases by age and sex.
RESULTS: After adjusting for potential confounders IHD was associated with a small increased risk of GB disease (1.29, 95%CI:1.08-1.55). When only cases requiring cholecystectomy were considered in the analysis, the resulting estimate was 1.06 (95%CI:0.83-1.35). Users of thiazide diuretics presented an OR of 1.36 (95%CI:1.08-1.71). Other antihypertensive drugs were not associated with GB disease.
CONCLUSIONS: Our results confirm the small increased risk of GB disease associated with thiazide diuretics. On the other hand, our data do not support a major association between IHD and GB disease. Copyright 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17103483     DOI: 10.1002/pds.1346

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  10 in total

1.  Gallstone disease is associated with increased mortality in the United States.

Authors:  Constance E Ruhl; James E Everhart
Journal:  Gastroenterology       Date:  2010-11-11       Impact factor: 22.682

Review 2.  Targets for current pharmacologic therapy in cholesterol gallstone disease.

Authors:  Agostino Di Ciaula; David Q H Wang; Helen H Wang; Leonilde Bonfrate; Piero Portincasa
Journal:  Gastroenterol Clin North Am       Date:  2010-06       Impact factor: 3.806

3.  Postmenopausal estrogen therapy and risk of gallstone disease: a population-based case-control study.

Authors:  Maja Hellfritzsch Simonsen; Rune Erichsen; Trine Frøslev; Jørgen Rungby; Henrik Toft Sørensen
Journal:  Drug Saf       Date:  2013-12       Impact factor: 5.606

Review 4.  Body mass index, abdominal fatness and the risk of gallbladder disease.

Authors:  Dagfinn Aune; Teresa Norat; Lars J Vatten
Journal:  Eur J Epidemiol       Date:  2015-09-15       Impact factor: 8.082

5.  Smoking habits and gallbladder disease: a systematic review and meta-analysis study.

Authors:  V Papadopoulos; D Filippou; K Mimidis
Journal:  Hippokratia       Date:  2020 Oct-Dec       Impact factor: 0.471

6.  Therapy of gallstone disease: What it was, what it is, what it will be.

Authors:  Piero Portincasa; Agostino Di Ciaula; Leonilde Bonfrate; David Qh Wang
Journal:  World J Gastrointest Pharmacol Ther       Date:  2012-04-06

7.  Gallbladder gallstone disease is associated with newly diagnosed coronary artery atherosclerotic disease: a cross-sectional study.

Authors:  Zhao-Yan Jiang; Xia Sheng; Chen-Ying Xu; Wei-Wei Li; Xian-Xing Chang; Lu-Ying Sun; Xiao-Bo Yang; Li-Fen Yu
Journal:  PLoS One       Date:  2013-09-18       Impact factor: 3.240

Review 8.  Tobacco smoking and the risk of gallbladder disease.

Authors:  Dagfinn Aune; Lars J Vatten; Paolo Boffetta
Journal:  Eur J Epidemiol       Date:  2016-02-22       Impact factor: 8.082

9.  The association between gallstone disease and plaque in the abdominopelvic arteries.

Authors:  Halil İbrahim Serin; Yunus Keser Yilmaz; Yaşar Turan; Ergin Arslan; Mustafa Fatih Erkoç; Aytaç Doğan; Mehmet Celikbilek
Journal:  J Res Med Sci       Date:  2017-01-27       Impact factor: 1.852

10.  Estimation of cardiosurgical intervention risk according to EuroSCORE in patients with acute coronary syndrome and different gallbladder conditions before coronary artery bypass grafting.

Authors:  Larysa Strilchuk; Dmytro Besh
Journal:  Kardiochir Torakochirurgia Pol       Date:  2018-12-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.